INVA vs TECH · P/E 3.6, rev $358.7M vs P/E 65, rev $1.22B
Innoviva Inc (INVA) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Innoviva Inc (INVA) is a biotechnology company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported INVA revenue for 2024-12-31 was $358.7M. Net income was $23.4M. Revenue was up 15.5% from 2023-12-31 to 2024-12-31. INVA currently screens at market cap $1.66B and trailing P/E 3.6.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
INVA currently screens at market cap $1.66B and trailing P/E 3.6. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the INVA and TECH stock pages for the full models.
Not investment advice.